| Open Document File Size: 155,04 KBShare Result on Facebook
City Burkhart / Stallings / / Company APTALIS Pharma US Inc. / USP / New England Journal / Forest Laboratories LLC / / IndustryTerm castor oil / pancrelipase products / soft acidic food / food mixture / pancrelipase product / pancreatic enzyme products / food consumption / ammonia solution / enzyme products / acidic food / manufacturing / healthcare professional / / MedicalCondition headache / skin disorders / hives / nausea / exocrine pancreatic insufficiency / anaphylaxis / infectious illness / mucosal irritation / Chronic high doses / distal intestinal obstruction syndrome / gout / lymphadenopathy / chronic pancreatitis / infectious agent / diarrhea / beta-hemolytic streptococcal infection / cystic fibrosis / constipation / neck pain / pruritus / gastrointestinal disorders / asthma / malnutrition / severe allergic reactions / abdominal pain / epistaxis / pre-existing carcinoma / severe allergy / steatorrhea present / Carcinogenesis / hyperuricemia and allergic reactions / ear pain / nasal congestion / allergy / viral disease / pancreatic insufficiency / pain / concomitant disease / urticaria / diseases / Allergic Reactions / Irritation / steatorrhea / rash / / MedicalTreatment nutritional support / enzyme replacement therapy / drug therapy / / Organization DOSAGE AND ADMINISTRATION / FDA / / / Product talc / Delayed-Release Capsules / ULTRESA capsules / ULTRESA capsule / / ProvinceOrState Virginia / South Carolina / Georgia / / PublishedMedium New England Journal of Medicine / / Region New England / / Technology Pharmacokinetics / / URL www.fda.gov/medwatch / /
SocialTag |
Microsoft Word - Final Ultresa PI[removed]doc